Clincosm LogoSign in Get a demo

stage ii multiple myeloma

Showing 26 - 48 of 48
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Cleveland (drug, radiation, procedure,

Terminated
  • Refractory Multiple Myeloma
  • +3 more
  • fludarabine phosphate
  • +7 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Feb 16, 2017

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Duarte, Rochester, Saint Louis

Withdrawn
  • Refractory Multiple Myeloma
  • +3 more
  • Duarte, California
  • +2 more
Dec 15, 2016

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Terminated
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +27 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 27, 2016

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Las Angeles (dexamethasone,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Las Angeles, California
    Veteran's Administration Medical Center
Dec 3, 2015

Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Los Angeles, Rochester, Seattle

Completed
Has Results
  • Refractory Multiple Myeloma
  • +2 more
  • Los Angeles, California
  • +3 more
Aug 4, 2015

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in South Africa, United States

Terminated
Has Results
  • Stage I Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +275 more
Jun 23, 2015

Multiple Myeloma, Refractory Multiple Myeloma, Stage I Multiple Myeloma Trial in Scottsdale, Rochester (plerixafor, filgrastim)

Completed
Has Results
  • Multiple Myeloma
  • +4 more
  • Scottsdale, Arizona
  • +1 more
Apr 24, 2015

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial (bortezomib, cyclophosphamide,

Withdrawn
  • Stage I Multiple Myeloma
  • +2 more
  • (no location specified)
Apr 23, 2015

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (obatoclax mesylate,

Terminated
Has Results
  • Refractory Multiple Myeloma
  • +3 more
  • obatoclax mesylate
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 9, 2015

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Boston (bortezomib, laboratory

Completed
Has Results
  • Stage I Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 29, 2014

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (sunitinib malate)

Completed
Has Results
  • Refractory Multiple Myeloma
  • +3 more
  • sunitinib malate
  • Rochester, Minnesota
    Mayo Clinic Cancer Research Consortium
May 12, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
Has Results
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +88 more
  • palifermin
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Feb 19, 2014

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Columbus (temsirolimus,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Columbus, Ohio
  • +1 more
Oct 10, 2013

Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Tampa (bortezomib, tipifarnib,

Terminated
  • Refractory Multiple Myeloma
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 7, 2013

Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Columbus (lenalidomide,

Completed
  • Refractory Multiple Myeloma
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Sep 27, 2013

Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Tumor Trial in United States (arsenic trioxide,

Withdrawn
  • Stage II Multiple Myeloma
  • +2 more
  • arsenic trioxide
  • +4 more
  • Glendale, Arizona
  • +18 more
Jul 9, 2013

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Cleveland (arsenic trioxide, ascorbic

Withdrawn
  • Stage I Multiple Myeloma
  • +3 more
  • arsenic trioxide
  • +10 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Center
Jul 9, 2013

Stage II Multiple Myeloma, Stage III Multiple Myeloma, Refractory Plasma Cell Tumor Trial in Little Rock, Bethesda (autologous

Completed
  • Stage II Multiple Myeloma
  • +2 more
  • autologous tumor cell vaccine
  • +3 more
  • Little Rock, Arkansas
  • +2 more
Jun 19, 2013

Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Boston (drug, biological, other)

Completed
  • Stage I Multiple Myeloma
  • +2 more
  • vincristine sulfate
  • +6 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
May 30, 2013

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute

Completed
  • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
  • +61 more
  • La Jolla, California
  • +4 more
Mar 26, 2013

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Duarte (drug, biological, procedure,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Duarte, California
    City of Hope
Feb 13, 2013

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Baltimore (bortezomib, vorinostat,

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Baltimore, Maryland
    University of Maryland Greenebaum Cancer Center
Feb 6, 2013

Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma Trial in Rochester (alvocidib)

Completed
  • Refractory Multiple Myeloma
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 15, 2013